Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Gole

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Cells|May 31, 2019
Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn's Disease-A Systematic Review and Gene Ontology AnalysisBoris Gole, Uroš Potočnik
Frontiers in Cell and Developmental Biology|July 11, 2015
Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanismBoris Gole, Lisa Wiesmüller
Cells|July 26, 2020
Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound ScreeningLarisa Goričan, Boris Gole, Uroš Potočnik
Oncoscience|May 27, 2016
Erratum: Replication stress in MLL-rearrangementsMichael Milyavsky, Boris Gole, Lisa Wiesmüller
Life Sciences|May 31, 2023
The expression IL1B correlates negatively with the clinical response to adalimumab in Crohn's disease patients: An ex vivo approach using peripheral blood mononuclear cellsBoris Gole, Cvetka Pernat, Gregor Jezernik, et al.
Pathology Oncology Research : POR|May 13, 2009
Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitroBoris Gole, María Beatriz Durán Alonso, Vincenc Dolenc, et al.
Genes|August 28, 2025
Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel DiseaseAnja Bizjak, Boris Gole, Gregor Jezernik, et al.
Foods (Basel, Switzerland)|May 25, 2024
Osmolality and Tonicity of Isotonic BeveragesTjaša Skarlovnik, Andraž Lamut, Gregor Hostnik, et al.
Scientific Reports|November 2, 2021
Metabolic profiling of attached and detached metformin and 2-deoxy-D-glucose treated breast cancer cells reveals adaptive changes in metabolome of detached cellsJernej Repas, Elmar Zügner, Boris Gole, et al.
Cancers|March 10, 2022
Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer CellsJernej Repas, Mateja Zupin, Maja Vodlan, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Cells|May 31, 2019
Pre-Treatment Biomarkers of Anti-Tumour Necrosis Factor Therapy Response in Crohn's Disease-A Systematic Review and Gene Ontology AnalysisBoris Gole, Uroš Potočnik
Frontiers in Cell and Developmental Biology|July 11, 2015
Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanismBoris Gole, Lisa Wiesmüller
Cells|July 26, 2020
Head and Neck Cancer Stem Cell-Enriched Spheroid Model for Anticancer Compound ScreeningLarisa Goričan, Boris Gole, Uroš Potočnik
Oncoscience|May 27, 2016
Erratum: Replication stress in MLL-rearrangementsMichael Milyavsky, Boris Gole, Lisa Wiesmüller
Life Sciences|May 31, 2023
The expression IL1B correlates negatively with the clinical response to adalimumab in Crohn's disease patients: An ex vivo approach using peripheral blood mononuclear cellsBoris Gole, Cvetka Pernat, Gregor Jezernik, et al.
Pathology Oncology Research : POR|May 13, 2009
Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitroBoris Gole, María Beatriz Durán Alonso, Vincenc Dolenc, et al.
Genes|August 28, 2025
Toward Precision Medicine: Molecular Biomarkers of Response to Tofacitinib in Inflammatory Bowel DiseaseAnja Bizjak, Boris Gole, Gregor Jezernik, et al.
Foods (Basel, Switzerland)|May 25, 2024
Osmolality and Tonicity of Isotonic BeveragesTjaša Skarlovnik, Andraž Lamut, Gregor Hostnik, et al.
Scientific Reports|November 2, 2021
Metabolic profiling of attached and detached metformin and 2-deoxy-D-glucose treated breast cancer cells reveals adaptive changes in metabolome of detached cellsJernej Repas, Elmar Zügner, Boris Gole, et al.
Cancers|March 10, 2022
Dual Effect of Combined Metformin and 2-Deoxy-D-Glucose Treatment on Mitochondrial Biogenesis and PD-L1 Expression in Triple-Negative Breast Cancer CellsJernej Repas, Mateja Zupin, Maja Vodlan, et al.
Pageof 3